Changes in c-reactive protein after tramadol and ibuprofen administration in mandibular third molar surgery: a double-blind randomized clinical trial study
,
Abstract
Introduction: Surgical removal of inferior third molar tooth is associated with post-operative complications such as pain, trismus and edema. Decreasing the post-operative inflammationand edema is one of the important goals in drug administration. For management of post-operative pain, nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids can be administered. C-reactive protein (CRP) is one of the best paraclinical parameters for evaluation of tissue inflammation.Materials and Methods: Thirty one patients aged 18 to 31years old were enrolled and evaluated in this randomized controlled clinical trial. They were classified into two groups, randomly.In one group, NSAID and in the other group tramadol was administered orally, after dental surgery. Blood samples were taken before procedure and 72 hours after procedure for CRP level evaluation.Results: Regardless of the type of drugs, CRP changes were statistically significant in both groups before and after operation. Elevation of CRP serum level was higher in tramadol groupin comparison to Ibuprofen group and the difference was statistically significant. (P.value<0.05).Conclusion: This study has shown that NSAIDs have more anti-inflammatory effect than opioids.Key words: Third molar surgery; opioid; C-reactive protein; ibuprofen.Shine B, de Beer FC, Pepys MB. Solid phase ra- dio-immuno-assays for human C-reactive protein. ClinChimActa. 1981; 117:13-23.
Stahl WM. Acute phase protein response to tis- sue injury. Crit Care Med. 1987; 15:545-50.
Maury CPJ, Teppo A-M, Raunio P: Control of the acute phase serum amyloid A and C-reactive pro- tein response: Comparison of total replacement of the hip and knee. Eur J Clinical Invest 1984;14:323,
Shih L-Y, Wu J-J, Yang D-J: Erythrocyte sedi- mentation rate and C-reactive protein values in patients with total hip arthroplasty. ClinOrthop 1988; 255:238-46.
Anderson, M. Removal of asymptomatic third mo- lars: Indications, contraindications and, risk and benefits. J Indiana Dent Assoc. 1998; 77:41.
Koerner KR, Medlin KE. Clinical procedures for J aniomax Res 2016; 3(3) :219-222third molar surgery. 2nd ed. South Sheridan: Pen- nWell; 1995.
Kugelberg CF. Periodontal healing two and four years after impacted lower third molar surgery. A comparative retrospective study. Int J Oral Maxil- lofacSurg 1990; 19(6):341-5.
Kristiansson M, Saraste L, Soop M, Sundqvist KG, horne A. Diminished interleukin-6 and Ceactive protein responses to laparoscopic versus open cholecystectomy. ActaAnaesthesiol Scand.1999;43:146–152.
Bamigbade TA, Langford RM. Tramadol hydro- chloride: an overview of current use. Hosp Med.1998; 59:373-6.
Gobetti JP. Controlling dental pain, review. J Am Dent Assoc. 1992; 123:47–52.
Iizuka T, Lindqvist C. Changes in C-reactive pro- tein associated with surgical treatment of mandib ular fractures. J Oral Maxillofac Surg. 1991 May;49(5):464-7
El-Sharrawy EA, El-Hakim IE, Sameeh E. Attenu- ation of C-reactive protein increases after exodon- tia by tramadol and ibuprofen. AnesthProg. 2006;53:78-82.
Buccellati C, Sala A, Ballerio R, Bianchib M. Tra- madol anti-inflammatory activity is not related to a direct inhibitory action on prostaglandin endop- eroxide synthases. Eur J Pain. 2000; 4:413-5.
| Files | ||
| Issue | Vol 3, No 3 (Summer 2016) | |
| Section | Original Article(s) | |
| Keywords | ||
| Third molar surgery opioid C-reactive protein ibuprofen. | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
